What if_

1 / 1

_you could detect
Alzheimer’s Disease from
a single tube of blood

What if_

1 / 1

_you could identify Alzheimer’s
years before conventional
diagnosis, while there is still
time to act

What if_

1 / 1

_you could determine which
Alzheimer’s treatments are
right for you and avoid those
with severe side effects?

Scroll

The technology is here

We need a revolution in diagnostics to match the recent innovations in therapeutics and treatments.

cf-mRNA can detect neurodegenerative disease, including Alzheimers, at its earliest stages, eliminate the need for invasive and inaccurate diagnostic procedures, and guide therapy.

Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs.

This minimally invasive approach eliminates the need for spinal taps and expensive, inaccurate brain scans. It allows repeat assessment of a patient’s disease state over time. It is evident that “liquid biopsy” holds advantages over a tissue biopsy in providing minimally invasive follow-up of patients in the clinical setting.